Overview

Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A

Status:
Completed
Trial end date:
2020-03-23
Target enrollment:
Participant gender:
Summary
To evaluate the safety and pharmacokinetics drug-drug interaction of YYC506-T and YYC506-A
Phase:
Phase 1
Details
Lead Sponsor:
Yooyoung Pharmaceutical Co., Ltd.